BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549: BRAF fusion variants

Journal of Neuropathology and Experimental Neurology

Volumn 71, Issue 1, 2012, Pages 66-72

  Lin, Alex ^a   Rodriguez, Fausto J ^a   Karajannis, Matthias A ^b,c   Williams, Susan C ^b   Legault, Genevieve ^c   Zagzag, David ^b,c   Burger, Peter C ^a   Allen, Jeffrey C ^c   Eberhart, Charles G ^a   Bar, Eli E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRAF; Brain tumor; Glioneuronal; MAPK; Pilocytic astrocytoma

Indexed keywords

B RAF KINASE; MEMBRANE PROTEIN; PROTEIN KIAA1549; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; DNA SEQUENCE; GENE FUSION; GENE IDENTIFICATION; GENE MUTATION; GLIOMA; HUMAN; HUMAN TISSUE; NEUROEPITHELIOMA; PILOCYTIC ASTROCYTOMA; PILOMYXOID ASTROCYTOMA; PLEOMORPHIC XANTHOASTROCYTOMA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; GLIOMA; HUMANS; INFANT; MALE; NEUROGLIA; NEURONS; POINT MUTATION; PROTO-ONCOGENE PROTEINS B-RAF; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84655167688     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e31823f2cb0     Document Type: Article

References (30)

1. Ohgaki H, Kleihues P. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 2005;64:479-89 (Pubitemid 40781150)
2. CBTRUS. Primary Brain Tumors in the United States, 2000-2004. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2008
3. Dirven CM, Mooij JJ, Molenaar WM. Cerebellar pilocytic astrocytoma: A treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst 1997;13:17-23 (Pubitemid 27104553)
4. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008;455:1061-68
5. Bar EE, Lin A, Tihan T, et al. Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 2008; 67:878-87
6. Jacob K, Albrecht S, Sollier C, et al. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 2009;101:722-33
7. Jones DT, Kocialkowski S, Liu L, et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 2008;68:8673-77
8. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 2008;118:1739-49 (Pubitemid 351632377)
9. Sievert AJ, Jackson EM, Gai X, et al. Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 2009;19:449-58
10. Yu J, Deshmukh H, Gutmann RJ, et al. Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma. Neurology 2009;73: 1526-31
11. Dasgupta B, Li W, Perry A, et al. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes. Cancer Res 2005; 65:236-45 (Pubitemid 40070815)
12. Jones DT, Kocialkowski S, Liu L, et al. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma. Oncogene 2009; 28:2119-23
13. Dougherty MJ, Santi M, Brose MS, et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 2010;12:621-30
14. Schindler G, Capper D, Meyer J, et al. Analysis of BRAFV600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 2011;121:397-405
15. Louis D, Ohgaki H, Wiestler O, et al. WHO Classification of Tumours of the Central Nervous System. 4th ed. Lyon, France: IARC Press, 2007
16. Bar EE, Chaudhry A, Farah MH, et al. Hedgehog signaling promotes medulloblastoma survival via Bc/II. Am J Pathol 2007;170:347-55 (Pubitemid 47339212)
17. Cin H, Meyer C, Herr R, et al. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma. Acta Neuropathol 2011;121:763-74
18. Rodriguez EF, Scheithauer BW, Giannini C, et al. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 2011;121: 407-20
19. Hawkins CE, Walker E, Mohamed N, et al. BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low grade astrocytoma. Clin Cancer Res 2011;17:4790-98
20. Jeuken JW, Wesseling P. MAPK pathway activation through BRAF gene fusion in pilocytic astrocytomas: A novel oncogenic fusion gene with diagnostic, prognostic, and therapeutic potential. J Pathol 2010;222:324-28
21. Rodriguez FJ, Perry A, Gutmann DH, et al. Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 2008;67:240-49 (Pubitemid 351483292)
22. Forshew T, Tatevossian RG, Lawson AR, et al. Activation of the ERK/ MAPK pathway: A signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol 2009;218:172-81
23. Lawson AR, Hindley GF, Forshew T, et al. RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. Genome Res 2011;21:505-14
24. Jacob K, Quang-Khuong DA, Jones DT, et al. Genetic aberrations leading to MAPK pathway activation mediate oncogene-induced senescence in sporadic pilocytic astrocytomas. Clin Cancer Res 2011;17:4650-60
25. Raabe EH, Lim KS, Kim JM, et al. BRAF activation induces transformation and then senescence in human neural stem cells: A pilocytic astrocytoma model. Clin Cancer Res 2011;17:3590-99
26. Lawson AR, Tatevossian RG, Phipps KP, et al. RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort. Acta Neuropathol 2010;120:271-73
27. Hasselblatt M, Riesmeier B, Lechtape B, et al. BRAF-KIAA1549 fusion transcripts are less frequent in pilocytic astrocytomas diagnosed in adults. Neuropathol Appl Neurobiol 2011;37:803-6.
28. Sharma MK, Mansur DB, Reifenberger G, et al. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res 2007;67:890-900
29. Taylor MD, Poppleton H, Fuller C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005;8:323-35 (Pubitemid 41443417)
30. Horbinski C, Hamilton RL, Nikiforov Y, et al. Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol 2010;119:641-49